Abstract
A select series of N(2)-substituted D,L-cycloserine derivatives were prepared a ndevaluated for inhibitory activity against purified alanine racemases (alr gene product) from Escherichia coli, Staphylococcus aureus, and Mycobacterium tuberculosis, as well as in a growth inhibition assay. N(2)-Modification led to loss of enzymatic inhibitory activity in most cases consistent with a recent proposal for cycloserine function.
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Alanine Racemase / antagonists & inhibitors*
-
Alanine Racemase / metabolism
-
Antibiotics, Antitubercular / chemical synthesis*
-
Antibiotics, Antitubercular / chemistry
-
Antibiotics, Antitubercular / pharmacology
-
Chromatography, Thin Layer
-
Cycloserine / analogs & derivatives*
-
Cycloserine / pharmacology
-
Enzyme Inhibitors / chemical synthesis*
-
Enzyme Inhibitors / chemistry
-
Enzyme Inhibitors / pharmacology*
-
Escherichia coli / drug effects
-
Escherichia coli / enzymology
-
Mass Spectrometry
-
Microbial Sensitivity Tests
-
Mycobacterium tuberculosis / drug effects
-
Mycobacterium tuberculosis / enzymology
-
Nuclear Magnetic Resonance, Biomolecular
-
Spectroscopy, Fourier Transform Infrared
-
Staphylococcus aureus / drug effects
-
Staphylococcus aureus / enzymology
-
Structure-Activity Relationship
Substances
-
Antibiotics, Antitubercular
-
Enzyme Inhibitors
-
Cycloserine
-
Alanine Racemase